{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:50:22Z","timestamp":1794610222306,"version":"4.9.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019729","name":"Japan Labour Health and Welfare Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019729","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.psychres.2024.115761","type":"journal-article","created":{"date-parts":[[2024,1,28]],"date-time":"2024-01-28T13:14:29Z","timestamp":1706447669000},"page":"115761","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A comparison of recurrence rates after discontinuation of second-generation antipsychotic long-acting injectable versus corresponding oral antipsychotic in the maintenance treatment of bipolar disorder: A systematic review"],"prefix":"10.1016","volume":"333","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9237-2236","authenticated-orcid":false,"given":"Taro","family":"Kishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6098-9266","authenticated-orcid":false,"given":"Leslie","family":"Citrome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakao","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.psychres.2024.115761_bib0001","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jad.2012.01.047","article-title":"A randomized, placebo- and active-controlled study of paliperidone extended-release as maintenance treatment in patients with bipolar I disorder after an acute manic or mixed episode","volume":"138","author":"Berwaerts","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.psychres.2024.115761_bib0002","doi-asserted-by":"crossref","first-page":"324","DOI":"10.4088\/JCP.16m11201","article-title":"Efficacy and safety of aripiprazole once-monthly in the maintenance treatment of bipolar I disorder: a double-blind, placebo-controlled, 52-week randomized withdrawal study","volume":"78","author":"Calabrese","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"9799","key":"10.1016\/j.psychres.2024.115761_bib0003","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.psychres.2024.115761_bib0004","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1600-0447.2008.01194.x","article-title":"Compelling or irrelevant? Using number needed to treat can help decide","volume":"117","author":"Citrome","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.psychres.2024.115761_bib0005","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.23m14873","article-title":"Safety and efficacy of aripiprazole 2-month ready-to-use 960 mg: secondary analysis of outcomes in adult patients with schizophrenia in a randomized, open-label, parallel-arm, pivotal study","volume":"84","author":"Citrome","year":"2023","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2024.115761_bib0006","unstructured":"FDA, U.S. Food and Drug Administration. https:\/\/www.fda.gov\/."},{"issue":"4","key":"10.1016\/j.psychres.2024.115761_bib0007","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/JCP.0000000000000523","article-title":"Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients: a systematic review","volume":"36","author":"Garcia","year":"2016","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.psychres.2024.115761_bib0008","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40263-023-00996-8","article-title":"A randomized, open-label, multiple-dose, parallel-arm, pivotal study to evaluate the safety, tolerability, and pharmacokinetics of aripiprazole 2-month long-acting injectable in adults with schizophrenia or bipolar I disorder","volume":"37","author":"Harlin","year":"2023","journal-title":"CNS. Drugs"},{"key":"10.1016\/j.psychres.2024.115761_bib0009","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.euroneuro.2022.07.185","article-title":"Barriers to managing bipolar I disorder with long-acting injectable antipsychotics","volume":"64","author":"Jawad","year":"2022","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2024.115761_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107704","article-title":"Antipsychotics: mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology","volume":"172","author":"Kaar","year":"2020","journal-title":"Neuropharmacology."},{"issue":"10","key":"10.1016\/j.psychres.2024.115761_bib0011","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4088\/JCP.v68n1003","article-title":"Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo","volume":"68","author":"Keck","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2024.115761_bib0012","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1038\/s41380-020-00946-6","article-title":"Mood stabilizers and\/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials","volume":"26","author":"Kishi","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"15","key":"10.1016\/j.psychres.2024.115761_bib0013","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1017\/S0033291720003505","article-title":"Recurrence rates in stable bipolar disorder patients after drug discontinuation v. drug maintenance: a systematic review and meta-analysis","volume":"51","author":"Kishi","year":"2021","journal-title":"Psychol. Med."},{"issue":"8","key":"10.1016\/j.psychres.2024.115761_bib0014","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/bdi.13053","volume":"23","author":"Kishi","year":"2021","journal-title":"Bipolar. Disord."},{"key":"10.1016\/j.psychres.2024.115761_bib0015","first-page":"1","article-title":"Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study","author":"Lahteenvuo","year":"2023","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2024.115761_bib0016","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jad.2023.04.030","article-title":"Non-adherence to mood stabilizers and antipsychotics among persons with bipolar disorder - A nationwide cohort study","volume":"333","author":"Lintunen","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"8","key":"10.1016\/j.psychres.2024.115761_bib0017","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1399-5618.2009.00761.x","article-title":"A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently","volume":"11","author":"Macfadden","year":"2009","journal-title":"Bipolar. Disord."},{"issue":"7","key":"10.1016\/j.psychres.2024.115761_bib0018","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/03007995.2023.2219155","article-title":"Safety and efficacy of aripiprazole 2-month ready-to-use 960 mg: secondary analysis of outcomes in adult patients with bipolar I disorder in a randomized, open-label, parallel-arm, pivotal study","volume":"39","author":"McIntyre","year":"2023","journal-title":"Curr. Med. Res. Opin."},{"issue":"14","key":"10.1016\/j.psychres.2024.115761_bib0019","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/jama.2023.18588","article-title":"Diagnosis and treatment of bipolar disorder: a review","volume":"330","author":"Nierenberg","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.psychres.2024.115761_bib0020","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.psychres.2024.115761_bib0021","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2024.115761_bib0022","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.biopsych.2010.01.015","article-title":"Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder","volume":"68","author":"Quiroz","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2024.115761_bib0023","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.euroneuro.2012.03.004","article-title":"A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder","volume":"22","author":"Vieta","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.psychres.2024.115761_bib0024","doi-asserted-by":"crossref","first-page":"e813","DOI":"10.4088\/JCP.16m11308","article-title":"Does half-life matter after antipsychotic discontinuation? A relapse comparison in schizophrenia with 3 different formulations of paliperidone","volume":"78","author":"Weiden","year":"2017","journal-title":"J. Clin. Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178124000465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178124000465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T02:25:48Z","timestamp":1736994348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178124000465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":24,"alternative-id":["S0165178124000465"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2024.115761","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparison of recurrence rates after discontinuation of second-generation antipsychotic long-acting injectable versus corresponding oral antipsychotic in the maintenance treatment of bipolar disorder: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2024.115761","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115761"}}